Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 16,214 | 11,190 | 0 |
| Cost of Goods | N/A | -24,743 | 14,398 | 10,345 | N/A |
| Gross Profit | N/A | -2,661 | 1,816 | 845 | N/A |
| Operating Expenses | 3,618 | -9,580 | 6,194 | 7,922 | 870 |
| Operating Income | -3,618 | 6,176 | -3,980 | -6,732 | -870 |
| Interest Expense | 131 | 484 | 522 | 389 | 91 |
| Other Income | -179 | -687 | -161 | -215 | 0 |
| Pre-tax Income | -3,928 | 5,005 | -4,663 | -7,336 | -961 |
| Income Tax | N/A | N/A | 90 | 139 | N/A |
| Net Income Continuous | -3,928 | 5,234 | -4,753 | -7,475 | -961 |
| Net Income Discontinuous | 10,268 | -14,121 | N/A | N/A | 1,419 |
| Net Income | $6,340 | $-8,887 | $-4,753 | $-7,475 | $458 |
| EPS Basic Total Ops | 5.01 | -10.95 | -4.83 | -14.21 | 1.41 |
| EPS Basic Continuous Ops | -3.11 | 10.92 | -4.83 | -14.14 | -2.96 |
| EPS Basic Discontinuous Ops | 8.12 | -21.95 | N/A | N/A | 4.37 |
| EPS Diluted Total Ops | 5.01 | -10.95 | -4.83 | -14.21 | 1.41 |
| EPS Diluted Continuous Ops | -3.11 | 10.92 | -4.83 | -14.14 | -2.96 |
| EPS Diluted Discontinuous Ops | 8.12 | -21.95 | N/A | N/A | 4.37 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -3.86 | -10.97 | 1.44 |
| EBITDA(a) | $-3,575 | $35,076 | $-3,028 | $-5,976 | $226 |